nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—psoriatic arthritis	0.736	1	CbGaD
Lisinopril—ABCB1—Methylprednisolone—psoriatic arthritis	0.0395	0.279	CbGbCtD
Lisinopril—ABCB1—Betamethasone—psoriatic arthritis	0.0257	0.182	CbGbCtD
Lisinopril—ABCB1—Prednisolone—psoriatic arthritis	0.0253	0.179	CbGbCtD
Lisinopril—ABCB1—Prednisone—psoriatic arthritis	0.0239	0.169	CbGbCtD
Lisinopril—ABCB1—Dexamethasone—psoriatic arthritis	0.0149	0.106	CbGbCtD
Lisinopril—ABCB1—Methotrexate—psoriatic arthritis	0.012	0.0849	CbGbCtD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—psoriatic arthritis	0.0043	0.411	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—psoriatic arthritis	0.0041	0.391	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—psoriatic arthritis	0.00113	0.108	CbGpPWpGaD
Lisinopril—Fosinopril—ACE—psoriatic arthritis	0.00112	0.152	CrCbGaD
Lisinopril—Spirapril—ACE—psoriatic arthritis	0.0009	0.123	CrCbGaD
Lisinopril—Moexipril—ACE—psoriatic arthritis	0.000863	0.118	CrCbGaD
Lisinopril—Cilazapril—ACE—psoriatic arthritis	0.000802	0.11	CrCbGaD
Lisinopril—Quinapril—ACE—psoriatic arthritis	0.000802	0.11	CrCbGaD
Lisinopril—Trandolapril—ACE—psoriatic arthritis	0.000777	0.106	CrCbGaD
Lisinopril—Ramipril—ACE—psoriatic arthritis	0.000777	0.106	CrCbGaD
Lisinopril—Benazepril—ACE—psoriatic arthritis	0.000698	0.0953	CrCbGaD
Lisinopril—Enalapril—ACE—psoriatic arthritis	0.000589	0.0804	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—ACE—psoriatic arthritis	0.000213	0.0204	CbGpPWpGaD
Lisinopril—Malaise—Betamethasone—psoriatic arthritis	0.00013	0.00124	CcSEcCtD
Lisinopril—Oedema—Triamcinolone—psoriatic arthritis	0.00013	0.00124	CcSEcCtD
Lisinopril—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00013	0.00124	CcSEcCtD
Lisinopril—Vertigo—Betamethasone—psoriatic arthritis	0.00013	0.00124	CcSEcCtD
Lisinopril—Vertigo—Dexamethasone—psoriatic arthritis	0.00013	0.00124	CcSEcCtD
Lisinopril—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00013	0.00124	CcSEcCtD
Lisinopril—Syncope—Dexamethasone—psoriatic arthritis	0.00013	0.00123	CcSEcCtD
Lisinopril—Syncope—Betamethasone—psoriatic arthritis	0.00013	0.00123	CcSEcCtD
Lisinopril—Arrhythmia—Prednisone—psoriatic arthritis	0.000129	0.00123	CcSEcCtD
Lisinopril—Infection—Triamcinolone—psoriatic arthritis	0.000129	0.00123	CcSEcCtD
Lisinopril—Sweating—Methotrexate—psoriatic arthritis	0.000129	0.00123	CcSEcCtD
Lisinopril—Infection—Methylprednisolone—psoriatic arthritis	0.000129	0.00123	CcSEcCtD
Lisinopril—Haematuria—Methotrexate—psoriatic arthritis	0.000128	0.00122	CcSEcCtD
Lisinopril—Shock—Triamcinolone—psoriatic arthritis	0.000128	0.00122	CcSEcCtD
Lisinopril—Insomnia—Prednisolone—psoriatic arthritis	0.000128	0.00122	CcSEcCtD
Lisinopril—Alopecia—Prednisone—psoriatic arthritis	0.000128	0.00122	CcSEcCtD
Lisinopril—Shock—Methylprednisolone—psoriatic arthritis	0.000128	0.00122	CcSEcCtD
Lisinopril—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	0.000127	0.0122	CbGpPWpGaD
Lisinopril—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—Epistaxis—Methotrexate—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—Paraesthesia—Prednisolone—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—Tachycardia—Triamcinolone—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—Mental disorder—Prednisone—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000127	0.00121	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	0.000127	0.0121	CbGpPWpGaD
Lisinopril—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000126	0.0012	CcSEcCtD
Lisinopril—Malnutrition—Prednisone—psoriatic arthritis	0.000126	0.0012	CcSEcCtD
Lisinopril—Erythema—Prednisone—psoriatic arthritis	0.000126	0.0012	CcSEcCtD
Lisinopril—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000126	0.0012	CcSEcCtD
Lisinopril—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000126	0.0012	CcSEcCtD
Lisinopril—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000125	0.00119	CcSEcCtD
Lisinopril—Myalgia—Dexamethasone—psoriatic arthritis	0.000123	0.00117	CcSEcCtD
Lisinopril—Myalgia—Betamethasone—psoriatic arthritis	0.000123	0.00117	CcSEcCtD
Lisinopril—Anxiety—Betamethasone—psoriatic arthritis	0.000123	0.00117	CcSEcCtD
Lisinopril—Anxiety—Dexamethasone—psoriatic arthritis	0.000123	0.00117	CcSEcCtD
Lisinopril—Discomfort—Dexamethasone—psoriatic arthritis	0.000122	0.00116	CcSEcCtD
Lisinopril—Discomfort—Betamethasone—psoriatic arthritis	0.000122	0.00116	CcSEcCtD
Lisinopril—Hypotension—Methylprednisolone—psoriatic arthritis	0.000121	0.00115	CcSEcCtD
Lisinopril—Pain—Prednisolone—psoriatic arthritis	0.000121	0.00115	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—psoriatic arthritis	0.000121	0.00115	CcSEcCtD
Lisinopril—Pharyngitis—Methotrexate—psoriatic arthritis	0.00012	0.00114	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000119	0.00114	CcSEcCtD
Lisinopril—Vision blurred—Prednisone—psoriatic arthritis	0.000119	0.00113	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—psoriatic arthritis	0.000119	0.00113	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000119	0.00113	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000118	0.00113	CcSEcCtD
Lisinopril—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000118	0.00112	CcSEcCtD
Lisinopril—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000118	0.00112	CcSEcCtD
Lisinopril—Oedema—Dexamethasone—psoriatic arthritis	0.000118	0.00112	CcSEcCtD
Lisinopril—Oedema—Betamethasone—psoriatic arthritis	0.000118	0.00112	CcSEcCtD
Lisinopril—Insomnia—Triamcinolone—psoriatic arthritis	0.000118	0.00112	CcSEcCtD
Lisinopril—Insomnia—Methylprednisolone—psoriatic arthritis	0.000117	0.00112	CcSEcCtD
Lisinopril—Infection—Betamethasone—psoriatic arthritis	0.000117	0.00112	CcSEcCtD
Lisinopril—Infection—Dexamethasone—psoriatic arthritis	0.000117	0.00112	CcSEcCtD
Lisinopril—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000117	0.00111	CcSEcCtD
Lisinopril—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000117	0.00111	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000117	0.00111	CcSEcCtD
Lisinopril—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000117	0.00111	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	0.000116	0.0111	CbGpPWpGaD
Lisinopril—Anaemia—Prednisone—psoriatic arthritis	0.000116	0.00111	CcSEcCtD
Lisinopril—Shock—Dexamethasone—psoriatic arthritis	0.000116	0.00111	CcSEcCtD
Lisinopril—Shock—Betamethasone—psoriatic arthritis	0.000116	0.00111	CcSEcCtD
Lisinopril—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000116	0.0011	CcSEcCtD
Lisinopril—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000116	0.0011	CcSEcCtD
Lisinopril—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000116	0.0011	CcSEcCtD
Lisinopril—Tachycardia—Betamethasone—psoriatic arthritis	0.000115	0.0011	CcSEcCtD
Lisinopril—Tachycardia—Dexamethasone—psoriatic arthritis	0.000115	0.0011	CcSEcCtD
Lisinopril—Angioedema—Prednisone—psoriatic arthritis	0.000115	0.0011	CcSEcCtD
Lisinopril—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000115	0.00109	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000114	0.00109	CcSEcCtD
Lisinopril—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000114	0.00109	CcSEcCtD
Lisinopril—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000114	0.00109	CcSEcCtD
Lisinopril—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000114	0.00109	CcSEcCtD
Lisinopril—Malaise—Prednisone—psoriatic arthritis	0.000114	0.00108	CcSEcCtD
Lisinopril—Vertigo—Prednisone—psoriatic arthritis	0.000113	0.00108	CcSEcCtD
Lisinopril—Syncope—Prednisone—psoriatic arthritis	0.000113	0.00108	CcSEcCtD
Lisinopril—Tinnitus—Methotrexate—psoriatic arthritis	0.000113	0.00107	CcSEcCtD
Lisinopril—Anorexia—Betamethasone—psoriatic arthritis	0.000113	0.00107	CcSEcCtD
Lisinopril—Anorexia—Dexamethasone—psoriatic arthritis	0.000113	0.00107	CcSEcCtD
Lisinopril—Urticaria—Prednisolone—psoriatic arthritis	0.000112	0.00107	CcSEcCtD
Lisinopril—Fatigue—Triamcinolone—psoriatic arthritis	0.000112	0.00107	CcSEcCtD
Lisinopril—Fatigue—Methylprednisolone—psoriatic arthritis	0.000112	0.00107	CcSEcCtD
Lisinopril—Pain—Triamcinolone—psoriatic arthritis	0.000111	0.00106	CcSEcCtD
Lisinopril—Loss of consciousness—Prednisone—psoriatic arthritis	0.000111	0.00105	CcSEcCtD
Lisinopril—Hypotension—Dexamethasone—psoriatic arthritis	0.00011	0.00105	CcSEcCtD
Lisinopril—Hypotension—Betamethasone—psoriatic arthritis	0.00011	0.00105	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—psoriatic arthritis	0.00011	0.00104	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000109	0.00104	CcSEcCtD
Lisinopril—Chills—Methotrexate—psoriatic arthritis	0.000108	0.00103	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	0.000108	0.0103	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000108	0.00102	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000108	0.00102	CcSEcCtD
Lisinopril—Arthralgia—Prednisone—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Myalgia—Prednisone—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Anxiety—Prednisone—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Insomnia—Dexamethasone—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Insomnia—Betamethasone—psoriatic arthritis	0.000107	0.00102	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000106	0.00101	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000106	0.00101	CcSEcCtD
Lisinopril—Paraesthesia—Betamethasone—psoriatic arthritis	0.000106	0.00101	CcSEcCtD
Lisinopril—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000106	0.00101	CcSEcCtD
Lisinopril—Discomfort—Prednisone—psoriatic arthritis	0.000106	0.00101	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—psoriatic arthritis	0.000106	0.00101	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—psoriatic arthritis	0.000105	0.001	CcSEcCtD
Lisinopril—Erythema—Methotrexate—psoriatic arthritis	0.000105	0.001	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000104	0.000992	CcSEcCtD
Lisinopril—Dyspepsia—Betamethasone—psoriatic arthritis	0.000104	0.000989	CcSEcCtD
Lisinopril—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000104	0.000989	CcSEcCtD
Lisinopril—Urticaria—Triamcinolone—psoriatic arthritis	0.000103	0.000984	CcSEcCtD
Lisinopril—Urticaria—Methylprednisolone—psoriatic arthritis	0.000103	0.000981	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—psoriatic arthritis	0.000103	0.000981	CcSEcCtD
Lisinopril—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000103	0.000979	CcSEcCtD
Lisinopril—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000103	0.000978	CcSEcCtD
Lisinopril—Oedema—Prednisone—psoriatic arthritis	0.000103	0.000978	CcSEcCtD
Lisinopril—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000103	0.000977	CcSEcCtD
Lisinopril—Decreased appetite—Betamethasone—psoriatic arthritis	0.000103	0.000977	CcSEcCtD
Lisinopril—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000103	0.000977	CcSEcCtD
Lisinopril—Infection—Prednisone—psoriatic arthritis	0.000102	0.000972	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000102	0.00097	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000102	0.00097	CcSEcCtD
Lisinopril—Back pain—Methotrexate—psoriatic arthritis	0.000102	0.000969	CcSEcCtD
Lisinopril—Fatigue—Dexamethasone—psoriatic arthritis	0.000102	0.000969	CcSEcCtD
Lisinopril—Fatigue—Betamethasone—psoriatic arthritis	0.000102	0.000969	CcSEcCtD
Lisinopril—Shock—Prednisone—psoriatic arthritis	0.000101	0.000963	CcSEcCtD
Lisinopril—Pain—Dexamethasone—psoriatic arthritis	0.000101	0.000961	CcSEcCtD
Lisinopril—Pain—Betamethasone—psoriatic arthritis	0.000101	0.000961	CcSEcCtD
Lisinopril—Tachycardia—Prednisone—psoriatic arthritis	0.0001	0.000955	CcSEcCtD
Lisinopril—Skin disorder—Prednisone—psoriatic arthritis	9.98e-05	0.00095	CcSEcCtD
Lisinopril—Hyperhidrosis—Prednisone—psoriatic arthritis	9.94e-05	0.000946	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—psoriatic arthritis	9.92e-05	0.000944	CcSEcCtD
Lisinopril—Anorexia—Prednisone—psoriatic arthritis	9.8e-05	0.000933	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—psoriatic arthritis	9.77e-05	0.00093	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—psoriatic arthritis	9.73e-05	0.000926	CcSEcCtD
Lisinopril—Feeling abnormal—Dexamethasone—psoriatic arthritis	9.73e-05	0.000926	CcSEcCtD
Lisinopril—Feeling abnormal—Betamethasone—psoriatic arthritis	9.73e-05	0.000926	CcSEcCtD
Lisinopril—Gastrointestinal pain—Betamethasone—psoriatic arthritis	9.65e-05	0.000919	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	9.65e-05	0.000919	CcSEcCtD
Lisinopril—Hypersensitivity—Triamcinolone—psoriatic arthritis	9.58e-05	0.000912	CcSEcCtD
Lisinopril—Hypersensitivity—Methylprednisolone—psoriatic arthritis	9.56e-05	0.00091	CcSEcCtD
Lisinopril—Malaise—Methotrexate—psoriatic arthritis	9.49e-05	0.000904	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—psoriatic arthritis	9.46e-05	0.0009	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—psoriatic arthritis	9.42e-05	0.000897	CcSEcCtD
Lisinopril—Urticaria—Betamethasone—psoriatic arthritis	9.38e-05	0.000893	CcSEcCtD
Lisinopril—Urticaria—Dexamethasone—psoriatic arthritis	9.38e-05	0.000893	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	9.36e-05	0.000891	CcSEcCtD
Lisinopril—Dizziness—Prednisolone—psoriatic arthritis	9.35e-05	0.00089	CcSEcCtD
Lisinopril—Asthenia—Triamcinolone—psoriatic arthritis	9.33e-05	0.000888	CcSEcCtD
Lisinopril—Body temperature increased—Dexamethasone—psoriatic arthritis	9.33e-05	0.000888	CcSEcCtD
Lisinopril—Abdominal pain—Dexamethasone—psoriatic arthritis	9.33e-05	0.000888	CcSEcCtD
Lisinopril—Abdominal pain—Betamethasone—psoriatic arthritis	9.33e-05	0.000888	CcSEcCtD
Lisinopril—Body temperature increased—Betamethasone—psoriatic arthritis	9.33e-05	0.000888	CcSEcCtD
Lisinopril—Asthenia—Methylprednisolone—psoriatic arthritis	9.31e-05	0.000886	CcSEcCtD
Lisinopril—Insomnia—Prednisone—psoriatic arthritis	9.3e-05	0.000885	CcSEcCtD
Lisinopril—Paraesthesia—Prednisone—psoriatic arthritis	9.23e-05	0.000879	CcSEcCtD
Lisinopril—Pruritus—Triamcinolone—psoriatic arthritis	9.2e-05	0.000876	CcSEcCtD
Lisinopril—Cough—Methotrexate—psoriatic arthritis	9.18e-05	0.000874	CcSEcCtD
Lisinopril—Pruritus—Methylprednisolone—psoriatic arthritis	9.18e-05	0.000874	CcSEcCtD
Lisinopril—Dyspepsia—Prednisone—psoriatic arthritis	9.05e-05	0.000861	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—psoriatic arthritis	8.96e-05	0.000853	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—psoriatic arthritis	8.96e-05	0.000853	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—psoriatic arthritis	8.96e-05	0.000853	CcSEcCtD
Lisinopril—Decreased appetite—Prednisone—psoriatic arthritis	8.94e-05	0.000851	CcSEcCtD
Lisinopril—Rash—Prednisolone—psoriatic arthritis	8.92e-05	0.000849	CcSEcCtD
Lisinopril—Dermatitis—Prednisolone—psoriatic arthritis	8.91e-05	0.000848	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	8.9e-05	0.000847	CcSEcCtD
Lisinopril—Diarrhoea—Methylprednisolone—psoriatic arthritis	8.88e-05	0.000845	CcSEcCtD
Lisinopril—Fatigue—Prednisone—psoriatic arthritis	8.86e-05	0.000844	CcSEcCtD
Lisinopril—Headache—Prednisolone—psoriatic arthritis	8.86e-05	0.000843	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—psoriatic arthritis	8.85e-05	0.000843	CcSEcCtD
Lisinopril—Constipation—Prednisone—psoriatic arthritis	8.79e-05	0.000837	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—psoriatic arthritis	8.66e-05	0.000824	CcSEcCtD
Lisinopril—Dizziness—Triamcinolone—psoriatic arthritis	8.6e-05	0.000819	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—psoriatic arthritis	8.59e-05	0.000818	CcSEcCtD
Lisinopril—Dizziness—Methylprednisolone—psoriatic arthritis	8.58e-05	0.000817	CcSEcCtD
Lisinopril—Infection—Methotrexate—psoriatic arthritis	8.53e-05	0.000812	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisone—psoriatic arthritis	8.47e-05	0.000806	CcSEcCtD
Lisinopril—Asthenia—Betamethasone—psoriatic arthritis	8.47e-05	0.000806	CcSEcCtD
Lisinopril—Asthenia—Dexamethasone—psoriatic arthritis	8.47e-05	0.000806	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—psoriatic arthritis	8.41e-05	0.000801	CcSEcCtD
Lisinopril—Gastrointestinal pain—Prednisone—psoriatic arthritis	8.41e-05	0.0008	CcSEcCtD
Lisinopril—Nausea—Prednisolone—psoriatic arthritis	8.4e-05	0.0008	CcSEcCtD
Lisinopril—Pruritus—Betamethasone—psoriatic arthritis	8.35e-05	0.000795	CcSEcCtD
Lisinopril—Pruritus—Dexamethasone—psoriatic arthritis	8.35e-05	0.000795	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—psoriatic arthritis	8.34e-05	0.000794	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—psoriatic arthritis	8.3e-05	0.00079	CcSEcCtD
Lisinopril—Vomiting—Triamcinolone—psoriatic arthritis	8.27e-05	0.000787	CcSEcCtD
Lisinopril—Vomiting—Methylprednisolone—psoriatic arthritis	8.25e-05	0.000786	CcSEcCtD
Lisinopril—Rash—Triamcinolone—psoriatic arthritis	8.2e-05	0.000781	CcSEcCtD
Lisinopril—Dermatitis—Triamcinolone—psoriatic arthritis	8.19e-05	0.00078	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—psoriatic arthritis	8.19e-05	0.000779	CcSEcCtD
Lisinopril—Rash—Methylprednisolone—psoriatic arthritis	8.18e-05	0.000779	CcSEcCtD
Lisinopril—Dermatitis—Methylprednisolone—psoriatic arthritis	8.18e-05	0.000778	CcSEcCtD
Lisinopril—Urticaria—Prednisone—psoriatic arthritis	8.17e-05	0.000777	CcSEcCtD
Lisinopril—Headache—Triamcinolone—psoriatic arthritis	8.15e-05	0.000776	CcSEcCtD
Lisinopril—Headache—Methylprednisolone—psoriatic arthritis	8.13e-05	0.000774	CcSEcCtD
Lisinopril—Abdominal pain—Prednisone—psoriatic arthritis	8.13e-05	0.000773	CcSEcCtD
Lisinopril—Body temperature increased—Prednisone—psoriatic arthritis	8.13e-05	0.000773	CcSEcCtD
Lisinopril—Diarrhoea—Betamethasone—psoriatic arthritis	8.08e-05	0.000769	CcSEcCtD
Lisinopril—Diarrhoea—Dexamethasone—psoriatic arthritis	8.08e-05	0.000769	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—psoriatic arthritis	8.03e-05	0.000764	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	7.83e-05	0.000745	CcSEcCtD
Lisinopril—Dizziness—Betamethasone—psoriatic arthritis	7.81e-05	0.000743	CcSEcCtD
Lisinopril—Dizziness—Dexamethasone—psoriatic arthritis	7.81e-05	0.000743	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—psoriatic arthritis	7.77e-05	0.00074	CcSEcCtD
Lisinopril—Nausea—Triamcinolone—psoriatic arthritis	7.73e-05	0.000735	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—psoriatic arthritis	7.71e-05	0.000734	CcSEcCtD
Lisinopril—Nausea—Methylprednisolone—psoriatic arthritis	7.71e-05	0.000734	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—psoriatic arthritis	7.66e-05	0.000729	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—psoriatic arthritis	7.64e-05	0.000727	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisone—psoriatic arthritis	7.57e-05	0.000721	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—psoriatic arthritis	7.56e-05	0.00072	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	7.53e-05	0.00719	CbGpPWpGaD
Lisinopril—Vomiting—Dexamethasone—psoriatic arthritis	7.5e-05	0.000714	CcSEcCtD
Lisinopril—Vomiting—Betamethasone—psoriatic arthritis	7.5e-05	0.000714	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—psoriatic arthritis	7.47e-05	0.000711	CcSEcCtD
Lisinopril—Rash—Dexamethasone—psoriatic arthritis	7.44e-05	0.000708	CcSEcCtD
Lisinopril—Rash—Betamethasone—psoriatic arthritis	7.44e-05	0.000708	CcSEcCtD
Lisinopril—Dermatitis—Dexamethasone—psoriatic arthritis	7.44e-05	0.000708	CcSEcCtD
Lisinopril—Dermatitis—Betamethasone—psoriatic arthritis	7.44e-05	0.000708	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	7.42e-05	0.000706	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—psoriatic arthritis	7.41e-05	0.000705	CcSEcCtD
Lisinopril—Headache—Dexamethasone—psoriatic arthritis	7.39e-05	0.000704	CcSEcCtD
Lisinopril—Headache—Betamethasone—psoriatic arthritis	7.39e-05	0.000704	CcSEcCtD
Lisinopril—Asthenia—Prednisone—psoriatic arthritis	7.37e-05	0.000702	CcSEcCtD
Lisinopril—Pain—Methotrexate—psoriatic arthritis	7.35e-05	0.000699	CcSEcCtD
Lisinopril—Pruritus—Prednisone—psoriatic arthritis	7.27e-05	0.000692	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—psoriatic arthritis	7.08e-05	0.000674	CcSEcCtD
Lisinopril—Diarrhoea—Prednisone—psoriatic arthritis	7.03e-05	0.000669	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—psoriatic arthritis	7.02e-05	0.000669	CcSEcCtD
Lisinopril—Nausea—Betamethasone—psoriatic arthritis	7.01e-05	0.000667	CcSEcCtD
Lisinopril—Nausea—Dexamethasone—psoriatic arthritis	7.01e-05	0.000667	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	7.01e-05	0.00669	CbGpPWpGaD
Lisinopril—Urticaria—Methotrexate—psoriatic arthritis	6.82e-05	0.00065	CcSEcCtD
Lisinopril—Dizziness—Prednisone—psoriatic arthritis	6.8e-05	0.000647	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—psoriatic arthritis	6.79e-05	0.000646	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—psoriatic arthritis	6.79e-05	0.000646	CcSEcCtD
Lisinopril—Vomiting—Prednisone—psoriatic arthritis	6.54e-05	0.000622	CcSEcCtD
Lisinopril—Rash—Prednisone—psoriatic arthritis	6.48e-05	0.000617	CcSEcCtD
Lisinopril—Dermatitis—Prednisone—psoriatic arthritis	6.48e-05	0.000616	CcSEcCtD
Lisinopril—Headache—Prednisone—psoriatic arthritis	6.44e-05	0.000613	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	6.37e-05	0.00609	CbGpPWpGaD
Lisinopril—Hypersensitivity—Methotrexate—psoriatic arthritis	6.33e-05	0.000602	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—psoriatic arthritis	6.16e-05	0.000587	CcSEcCtD
Lisinopril—Nausea—Prednisone—psoriatic arthritis	6.11e-05	0.000581	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—psoriatic arthritis	6.08e-05	0.000579	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—psoriatic arthritis	5.88e-05	0.000559	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—psoriatic arthritis	5.68e-05	0.000541	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—psoriatic arthritis	5.46e-05	0.00052	CcSEcCtD
Lisinopril—Rash—Methotrexate—psoriatic arthritis	5.42e-05	0.000516	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—psoriatic arthritis	5.41e-05	0.000515	CcSEcCtD
Lisinopril—Headache—Methotrexate—psoriatic arthritis	5.38e-05	0.000512	CcSEcCtD
Lisinopril—Nausea—Methotrexate—psoriatic arthritis	5.1e-05	0.000486	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	3.01e-05	0.00288	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	1.49e-05	0.00142	CbGpPWpGaD
